FAQs about Testing in the Time of COVID-19

A great deal of our public attention and private conversations remain focused on testing for COVID-19.  We are encouraged by public health and government officials to get tested and that we need increased testing to understand the pandemic to more safely open our society.   Unfortunately, many of the messages are short sound bites and are thus confusing.  Even the knowledgeable reader/listener must furiously dig for details because some public proclamations can be misleading.  This document is an attempt to clarify some of the critical issues around COVID testing to help you determine whether testing is indicated for you, your family, and/or your employees (if you are an employer).

(Updated 7/31/2020)

Currently there are two major types of tests, each with a particular purpose.  Swab testing seeks to identify an active infection by looking for the virus itself (or some of the proteins known to make up the virus), and a positive swab test is an indication of current or active infection.

Some patients with the virus and/or a positive swab test have active symptoms (fever, cough, shortness of breath, chills, fatigue, headache, muscle pain, sore throat, shaking chills, or new loss of taste or smell, vomiting or diarrhea) while others have NO symptoms (asymptomatic).  In either situation, a patient may test positive and is considered contagious for the disease.  A negative test in a symptomatic patient does NOT guarantee they do not have the disease as there can be problems with the specimen collection or lab error.

Antibody tests (AB) seek to determine if a patient had a prior infection, not an active infection.  Antibodies are of two types: a short lived one which may appear in blood as early as 3 days after the onset of symptoms, and one that persists for a longer period but is not detectable until 14 days after the onset of symptoms.

Swab testing as the name would imply, involves placing a device into either the nose or mouth to collect a specimen.  Initially the most widely used swab test for COVID-19 was a nasopharyngeal (way back in your nose to absorb some mucous in that area) swab.  Other types of swabs have gained acceptance as testing abilities have improved.  Today many swab tests are performed by the patient or parent while the health care professional monitors to ensure the procedure is followed.   Patient self-collections have proven to be effective, require use of less personal protective equipment and are now the primary collection method at most centers.

Antibody tests, commonly referred to as either blood or serum tests (serum is the fluid portion of blood left when all the cells are removed) is the source.  The blood can be obtained typically by removing a tube of blood from the arm or for some tests, a finger stick.

As of this writing NO tests (either swab or antibody) have FDA “approval”.  There are several tests among the myriad being marketed which have “authorization” from the FDA (a much lower level of evaluation) under a rule known as Emergency Use Authorization (EUA).

Therefore, you should ensure that the provider of your test (either antigen or antibody) has at least achieved EUA before undergoing the test.

Until recently all approved tests were performed only in a laboratory setting.   A specimen (either swab or blood) was collected at a site and sent to the lab where the actual testing took place.

As of this writing, there is currently no AB test which has been authorized to be performed (both collection and testing) in an office or clinic setting.  Therefore, those considering AB testing should ensure their blood is sent to a lab as results from finger stick or rapid AB tests are considered unreliable.

Until May 8, 2020 there was likewise no option for swab testing other than to send the specimen to a lab for testing.  The FDA provided EUA to Quidel for a Rapid in-office Ag test that we are currently using in our clinics.

The test is named Sofia® 2 SARS Antigen FIA, the rapid-point-of-care test uses a fluorescent immunoassay analyzer for the rapid detections of SARS-CoV-2 in a nasal or nasopharyngeal specimen. The results are available in as little as 15 minutes. The sensitivity of the test (a measure of false negatives) is 96.7%, which compares very favorably to the lab-based tests which to this point have averaged 70%.

Through the first three months of the pandemic the only swab test was the lab-based PCR.    This remains the post commonly provided test of active infection at this time.  Unfortunately results typically take at least 2 days to obtain and in many cases waits are 7-10 days or even longer.  A PCR tests for the genetic material (RNA) which comprises the virus.  As with any test results are not perfect and there is a wide range of how sensitive (good at finding those who have the disease) might be.

The Rapid Ag tests available since mid-May detect proteins which are part of the viral make-up.   Initial studies showed they missed some of the positives (1 in 5) that could be detected by the more cumbersome PCR.   More recently studies (early July) show that both the negative test results and the positive test results are as reliable as the PCR.

The test is named Sofia® 2 SARS Antigen FIA and is produced by the Quidel Company.  The rapid-point-of-care test uses a fluorescent immunoassay analyzer for the rapid detections of SARS-CoV-2 from a nasal specimen.  The results are available in as little as 15 minutes.  The accuracy of this test for both positive and negative results has been shown to equal a lab tested swab or PCR test.

Rapid Ag testing is provided at Texas MedClinic for both those with symptoms and those without symptoms.  This later group includes both those we are exposed and those with no known exposure but who have a reason for concern.

This describes five populations for which SARS-CoV-2 testing with viral tests (i.e., nucleic acid or antigen tests) is appropriate:

A positive Ag test means the person tested has the virus, has an active infection, and, in most cases, should be considered actively contagious to others.  As such, they should be in isolation.  There is evidence that late in the disease, Ag can remain present in some patients, but they are not contagious.  Anyone who tests positive to an Antigen test should follow the advice of their physician or health care advisor regarding ending their isolation.

At present the only group for whom this is recommended by Public Health officials is for those patients who have recovered from a swab positive proven illness with COVID-19 and who are participating in donation of plasma.   Plasma donation remains an experimental treatment for those who are seriously ill with COVID-19.

At present, there are no national, state or local guidelines recommending antibody testing for any other group.  This is recognized as an area for a great deal more research.

Unfortunately, the answer to this question is unclear.  A positive AB test is presumed by many to indicate a person has developed resistance and is thus immune to a repeat COVID-19 infection due to a prior infection.  This has NOT been proven with COVID-19.  While there are many types of viral infections for which a patient may produce antibodies either after contracting or being vaccinated against the disease, (i.e. measles, chicken pox) this statement does not apply to every type of viral infection; hence the doubt and the controversy.  More time and more research are necessary to understand the meaning of a positive antibody test with COVID 19.

Another concern is that if, in fact, the presence of antibodies does ultimately provide immunity, and it is unclear how long the immunity might last; is it one year?  Three years?  Lifetime (doubtful)?

The public has a great deal of curiosity about antibody testing and many want to “know my status”.  However, if tested, a positive test should NOT be a license to take increased risks with one’s own health or that of others.   A positive test should NOT be used to discontinue or reduce social distancing, hand washing or use of masks.  Until we know more about antibody testing, the behavior of both the positive antibody group and the negative antibody group should remain the same as it has been since the beginning of this disease process.   As noted above, at present we do NOT know if a positive antibody test provides any protection.

An AB test CANNOT be used to determine whether a person does or does NOT have a current infection with COVID-19.

If you have symptoms of COVID-19, the answer is yes, you should be tested with a swabbing test, and isolate while awaiting the results.  For a positive test, isolation should continue until all three of the following criteria are met:

  • At least 10 days have passed since symptoms first appeared and
  • At least 24 hours have passed since last fever without the use of fever-reducing medications and Symptoms (e.g., cough, shortness of breath) have improved

A negative test should be interpreted by your health care provider since false negatives can occur.  A negative test alone, in the face of symptoms should follow the same return to life guidelines as for the positive test results.

It is understandable that individuals and organizations may desire an AB test for reassurance and the possible social, economic, and workplace benefits of immunity.  While the accuracy of these tests is improving, they are currently NOT recommended by Public Health authorities given the concerns about their validity, and, in addition, whether a positive test indeed implies immunity.  Unvalidated testing of this type has the potential to leave patients with a false sense of security by allowing them to believe they are immune to COVID-19 when they may not be, and act accordingly.  However, this could change as research advances our understanding of the disease, the testing process, and the true immunity the disease conveys.

The accuracy of some AB tests has continued to improve with time such that a hand-full of currently available, lab-based tests have a false positive rate of near 0%.  At this level of accuracy, while we at TMC continue to have concerns about the use to which AB test results might be placed, we are now reasonably confident the results of some tests are accurate.  Specifically, we work with our lab partners and provide the Quidel immunoassay, a test using serum or plasma drawn from a blood sample, to detect antibodies and determine the body’s immune reaction to SARS-CoV-2.

An antibody test may or may not be considered a covered service by most insurance carriers.  However, given there is no current medical indication, it is not clear if carriers will pay for all or part of the test.  They may determine this is 100% patient responsibility.  As such there may be a direct cost to the patient for the test and any associated medical evaluation.

If deciding to undergo AB testing it is important to find a reputable medical office to provide the test.  This will include obtaining a blood specimen and sending that specimen to a lab for testing.  Office based AB test are not considered reliable, nor are all lab-based AB tests. Expect results to take about 48 hours.

No.  Swab testing for the presence of the virus is merely a snapshot of a moment in time.  A negative test today does not ensure the person will remain negative tomorrow, or in one or two weeks.  In fact, VERY early in the course of the disease it is possible a person is “incubating” (in the process of developing the infection after an exposure) but the virus is not detectable by testing.  Except in certain unique situations, it is also not practical to test employees repeatedly.

Antibody testing is likewise NOT recommended in settings such as employer groups. In the future, it is possible this recommendation could change and thus ongoing attention to the matter is recommended.

No, as of July 16th the CDC no longer recommends any routine test of cure after a positive before a person returns to their normal environment.  Provided the 3 criteria of at least 10 days since onset of symptoms, no fever for 24 hours and symptoms improving have been met repeat testing is unnecessary.  Not only is it waste of scarce resources, the evidence is that those persons who continue to test positive are no longer contagious.  They merely have viral remnants that cannot infect other present in their secretions.   Further, the Families First Coronavirus Act has clarified that employer required testing is not included in the no cost sharing by patients.  Thus someone other than the carrier will need to pay for this type of testing.

The Center for Disease Control and local metropolitan health districts are the primary up-to-date sources for more information.   Individuals may wish to consult with their personal physician or health advisor.  If none is available, please visit our website at to schedule a visit time and meet with a physician expert.

Employers may wish to obtain consulting services from an expert who can evaluate the details of their unique business.  Please contact our Director of Business Development and Marketing, Leah Martinez at or 210-349-5577, Ext 8521 for more details and to learn about options and pricing.

Urgent Care Online Check-In with Texas MedClinic

We have visited this clinic several times. We always get back quicker then what our estimated wait time is. The staff is very friendly! They take their time and are thorough with their care. They engage with my children and make them feel very comfortable. Highly recommend.

- Kayla K.
IH 35 N / Bass Pro Drive Clinic
© 2020 Texas MedClinic®. All Rights Reserved. Phone: (210) 349-5577 |
San Antonio Website Design & Development - Backyard Studios